Radiation for Basal and Squamous Skin Cancer: Who Is a Candidate?

Short answer: Radiation can cure selected basal cell carcinomas (BCC) and cutaneous squamous cell carcinomas (cSCC), either instead of surgery or after surgery for high-risk features. It is not the default for every lesion, and the pathology must be understood before treatment.

When is radiation used instead of surgery?

ASTRO recommends definitive radiation when a patient cannot undergo curative surgery. It conditionally supports radiation when a patient declines surgery after learning the risks and benefits or when surgery may cause unacceptable functional or cosmetic impact.

Examples can include medically frail patients, people taking medications that complicate surgery, or selected lesions in areas where reconstruction would be difficult. These are discussion points—not automatic indications.

What tumor details matter?

The team should review:

• biopsy-confirmed diagnosis and subtype;
• tumor diameter and estimated depth;
• borders and location;
• primary versus recurrent disease;
• perineural, lymphovascular, bone, or cartilage involvement;
• immune suppression; and
• regional lymph-node risk.

Very superficial lesions may be treated with superficial x-rays. Deeper or irregular targets may require electrons, photons, brachytherapy, or another technique. The word “superficial” should not be used to minimize a tumor's risk.

When is postoperative radiation considered?

Radiation after surgery may be discussed when margins are positive and further excision is not feasible, or when other features create substantial recurrence risk. Extensive perineural invasion, deep invasion, recurrent disease, and certain nodal findings can change recommendations.

Not every microscopic risk feature requires radiation. The expected benefit should be weighed against the treated area's healing, function, and prior procedures.

Who may not be a good candidate?

Important cautions include prior radiation that limits safe retreatment, certain connective-tissue disorders, very young age, poor ability to attend treatment or follow-up, and a diagnosis better managed by another approach.

Melanoma is biologically different from routine BCC and cSCC. It requires melanoma-specific staging and multidisciplinary care.

What should patients ask?

Ask why surgery is or is not preferred, whether Mohs margin control is feasible, what radiation depth and schedule are planned, what skin reaction to expect, and what long-term follow-up is required. The right treatment comes from matching technique to pathology—not choosing “surgery-free” care before the cancer's risk is known.

Questions patients often ask

Can radiation treat both basal and squamous cell carcinoma?

Yes, in selected cases. Histology, depth, size, location, recurrence risk, and patient factors determine whether radiation is appropriate.

Is superficial radiation used for melanoma?

Routine superficial treatment of basal or squamous cancer should not be generalized to melanoma, which has different staging and treatment pathways.

Why might radiation be used after surgery?

It may be considered when margins remain involved and cannot be re-excised or when features such as substantial perineural invasion create a high recurrence risk.

Sources and further reading

1. ASTRO Guideline on Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers. American Society for Radiation Oncology (2020).
2. The Role of Radiation Therapy in the Treatment of Non-Melanoma Skin Cancer. Cancers (2023).
3. Expert opinion: radiotherapy for basal cell carcinoma. Strahlentherapie und Onkologie (2026).